Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Atezolizumab
Related studies linked through entity extraction aliases.
LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE1
A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
- Status
- RECRUITING
- Phase
- PHASE2
OT-101 in Combination With Atezolizumab for the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.
- Status
- COMPLETED
- Phase
- N/A
NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Panomic Approach to Immune-Connected Assays in Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2